PLACENTAL MACROPHAGES FOR CELL THERAPY
Research output: Intellectual Property › Patent application/Patent
Contributors
Abstract
The present invention to the use of human term placenta as a source of HLA-matched cells for use in cell therapy, in particular wherein the cells are non-maternal macrophages. The invention also relates to two different sets of isolated placental macrophages of embryonic origin, which have been newly discovered and identified as being useful for macrophage cell therapy, and to methods to isolate these cells from human term placenta.
Details
The present invention to the use of human term placenta as a source of HLA-matched cells for use in cell therapy, in particular wherein the cells are non-maternal macrophages. The invention also relates to two different sets of isolated placental macrophages of embryonic origin, which have been newly discovered and identified as being useful for macrophage cell therapy, and to methods to isolate these cells from human term placenta.
| Original language | English |
|---|---|
| IPC (International Patent Classification) | C12N 5/ 0786 A I |
| Patent number | WO2023094436 |
| Country/Territory | Germany |
| Priority date | 26 Nov 2021 |
| Priority number | EP20210210741 |
| Publication status | Published - 1 Jun 2023 |